SE436279B - 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)pyrimidiner - Google Patents

2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)pyrimidiner

Info

Publication number
SE436279B
SE436279B SE7808771A SE7808771A SE436279B SE 436279 B SE436279 B SE 436279B SE 7808771 A SE7808771 A SE 7808771A SE 7808771 A SE7808771 A SE 7808771A SE 436279 B SE436279 B SE 436279B
Authority
SE
Sweden
Prior art keywords
oxo
pyrido
hydrogen
pyrimidine
salts
Prior art date
Application number
SE7808771A
Other languages
English (en)
Swedish (sv)
Other versions
SE7808771L (sv
Inventor
I Hermecz
F Fulop
Z Meszaros
J Knoll
G Bernath
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7808771L publication Critical patent/SE7808771L/xx
Publication of SE436279B publication Critical patent/SE436279B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7808771A 1977-08-19 1978-08-18 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)pyrimidiner SE436279B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1766A HU182009B (en) 1977-08-19 1977-08-19 Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines

Publications (2)

Publication Number Publication Date
SE7808771L SE7808771L (sv) 1979-02-20
SE436279B true SE436279B (sv) 1984-11-26

Family

ID=10994668

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7808771A SE436279B (sv) 1977-08-19 1978-08-18 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)pyrimidiner

Country Status (21)

Country Link
US (1) US4220771A (ja)
JP (1) JPS5459299A (ja)
AT (1) AT371818B (ja)
BE (1) BE869833A (ja)
CA (1) CA1117525A (ja)
CH (1) CH638207A5 (ja)
CS (1) CS240351B1 (ja)
DD (1) DD138902A5 (ja)
DE (1) DE2836449A1 (ja)
DK (1) DK157021C (ja)
ES (1) ES473182A1 (ja)
FI (1) FI67547C (ja)
FR (1) FR2416893A1 (ja)
GB (1) GB2003870B (ja)
GR (1) GR65275B (ja)
HU (1) HU182009B (ja)
NL (1) NL7808571A (ja)
PL (1) PL116688B1 (ja)
SE (1) SE436279B (ja)
SU (1) SU749365A3 (ja)
YU (1) YU196578A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348396A (en) * 1978-01-23 1982-09-07 Hoffmann-La Roche Inc. Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them
US4395549A (en) * 1981-10-02 1983-07-26 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. 6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones
ES8406476A1 (es) * 1982-04-29 1984-07-01 Erba Farmitalia Procedimiento para preparar derivados cicloalifaticos condensados de pirido(1,2-a)pirimidinas sustituidas.
HU191192B (en) * 1982-11-16 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing new azepino /1,2-a/ pyrimidine derivatives of bronchodilating activity and acid additional salts thereof and pharmaceiutical compositions containing them
CA2113115A1 (en) * 1991-07-29 1993-02-18 Vlad E. Gregor Quinazoline derivatives as acetylcholinesterase inhibitors
US5892917A (en) * 1995-09-27 1999-04-06 Microsoft Corporation System for log record and log expansion with inserted log records representing object request for specified object corresponding to cached object copies
WO2011075699A2 (en) * 2009-12-18 2011-06-23 Sunovion Pharmaceuticals Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992221A (en) * 1958-07-03 1961-07-11 Petersen Siegfried Polymethylene-oxoquinazolines and their production
DE1088968B (de) 1958-07-03 1960-09-15 Bayer Ag Verfahren zur Herstellung von mehrkernigen, heterocyclischen, einen 4-Oxo-3, 4-dihydro-pyrimidinring enthaltenden Verbindungen
US3271396A (en) * 1964-08-17 1966-09-06 Squibb & Sons Inc Pyrido-quinazoline derivatives
DE1803785A1 (de) * 1968-10-18 1970-06-04 Hoechst Ag Verfahren zur Herstellung von 1,2-disubstituierten 6-Oxo-1.4.5.6-tetrahydropyrimidinen
US3790573A (en) * 1971-11-11 1974-02-05 Smithkline Corp Imidazo and pyrimido(2,1-b)quinazolines
US3965100A (en) * 1975-02-26 1976-06-22 E. R. Squibb & Sons, Inc. 2,3-Dihydrocyclopenta[d]pyrido[1,2-a]pyrimidin-10(1H)-one and its derivatives
US4033961A (en) * 1975-10-07 1977-07-05 Warner-Lambert Company Pyrido[2-1-b]quinazolin-ones and their methods of preparation
DE2557425C2 (de) * 1975-12-19 1987-03-19 C.H. Boehringer Sohn, 6507 Ingelheim 11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel
JPH0297996A (ja) * 1988-10-05 1990-04-10 Toshiba Corp 画像データ変換回路

Also Published As

Publication number Publication date
FI782517A (fi) 1979-02-20
ATA597178A (de) 1982-12-15
CH638207A5 (de) 1983-09-15
CA1117525A (en) 1982-02-02
ES473182A1 (es) 1979-04-01
FR2416893A1 (fr) 1979-09-07
US4220771A (en) 1980-09-02
DE2836449A1 (de) 1979-03-22
DK367378A (da) 1979-02-20
GB2003870B (en) 1982-07-21
CS541878A1 (en) 1985-05-15
JPS5459299A (en) 1979-05-12
SE7808771L (sv) 1979-02-20
NL7808571A (nl) 1979-02-21
HU182009B (en) 1983-12-28
DE2836449C2 (ja) 1990-09-06
PL209131A1 (pl) 1979-06-04
GR65275B (en) 1980-07-31
DK157021B (da) 1989-10-30
FI67547B (fi) 1984-12-31
YU196578A (en) 1983-10-31
AT371818B (de) 1983-08-10
GB2003870A (en) 1979-03-21
SU749365A3 (ru) 1980-07-15
PL116688B1 (en) 1981-06-30
DD138902A5 (de) 1979-11-28
BE869833A (fr) 1978-12-18
FI67547C (fi) 1985-04-10
DK157021C (da) 1990-04-02
FR2416893B1 (ja) 1983-07-22
CS240351B1 (en) 1986-02-13

Similar Documents

Publication Publication Date Title
EP1611133B1 (en) Condensed n-heterocyclic compound and use thereoff as crf receptor antagonist
US6245769B1 (en) Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
NL1026028C2 (nl) Cannabinoïdreceptorliganden en toepassingen daarvan.
EP0590428B1 (de) Azachinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3780263T2 (de) Imidazopyridinverbindungen und verfahren zu ihrer herstellung.
AU641005B2 (en) Heterocyclic N-substituted derivatives, their preparation and thepharmaceutical compositions containing them
DE69728676T2 (de) Substituierte 6,6-heterobicyclische derivate
PL171766B1 (pl) Sposób wytwarzania imidazo-skondensowanych zwiazków izo-i heterocyklicznych PL PL
AU578813B2 (en) Pyrido (2,3-d) pyrimidin derivatives
JPH11501924A (ja) 置換Ｎ−シクロアルキルメチル−１Ｈ−ピラゾロ〔３，４−ｂ〕キノリン−４−アミン、それを含む組成物およびそれの使用方法
EP1583531B1 (en) Heteroaryl-substituted pyrrolo[2, 3- b]pyridine derivatives as crf receptor antagonists
EP0098448A2 (de) Neue Imidazolderivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
CA2822003A1 (en) Imidazopyridines as respiratory syncytial virus antiviral agents
TW200424208A (en) Cannabinoid receptor ligands and uses thereof
IE83625B1 (en) Imidazopyridine
CA1340792C (en) Pyrido[2,3-d]pyrimidine deratives
JPH07500591A (ja) 三環性キノキサリンジオン化合物
US4219649A (en) Pyrido[1,2-a]pyrimidine derivatives
JP4953457B2 (ja) プロゲステロン受容体モジュレーターとしてのピリジンイミダゾール及びアザ−インドール
SE436279B (sv) 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)pyrimidiner
CH682151A5 (ja)
Mederski et al. Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4, 5-dihydro-4-oxo-3H-imidazo [4, 5-c] pyridine derivatives
AU658631B2 (en) New hetaryloxy-beta-carbolines, their production and use in pharmaceutical agents
Fülöp et al. Nitrogen bridgehead compounds. IX. Synthesis and reactions of 2, 3‐disubstituted pyrido [1, 2‐a] pyrimidin‐4‐ones
JP3480575B2 (ja) 新規ピリジニウム塩及びヘリコバクター細菌に基因する疾患を治療するための医薬品

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7808771-5

Effective date: 19920306

Format of ref document f/p: F